Summary

IV equipment is specifically designed to facilitate the administration of fluids, medications, or nutrients directly into the patient's veins. This method allows for rapid and controlled delivery of substances into the bloodstream, ensuring efficient absorption and distribution throughout the body. IV equipment plays a critical role in healthcare settings, enabling healthcare professionals to deliver essential treatments and therapies effectively. Key factors driving the industry expansion include the rising prevalence of chronic diseases, technological advancements in novel drug delivery systems, increasing healthcare expenditure, and the demand for efficient patient care. The IV infusion equipment market covers the global market for devices and products specially designed to administer fluids, medications, or therapeutic agents via veins in a patient's body. These devices are of great importance in a wide range of healthcare settings, from hospitals to medical centers and health services at home. The market for IV infusion equipment covering a broad range of instruments and products to administer liquids, medications or treatments directly in the patient's vein is an important part of the worldwide healthcare industry. In a variety of healthcare settings, including hospitals, doctor's offices, rehabilitation centers and home care which serve all age groups and illnesses, this market has an important role. These devices are used to monitor the rate and volume of fluids or medicinal products delivered through an IV so as to be sure that they are administered accurately and precisely. They are especially important for patients requiring periodic infusion therapy in the intensive care units, surgery settings and to patients with continuous infusion therapy. The increasing prevalence of chronic diseases, such as cardiovascular disorders, cancer, and diabetes, has led to a rise in the demand for IV therapies. In addition, access to health services has been increased and IV equipment is used more widely in developing countries due to the development of healthcare infrastructure. The importance of intravenous equipment to the global healthcare landscape has been further stressed by the COVID-19 pandemic. The demand for the reliability and efficiency of IV devices has grown due to the administration of vaccines, and treatment with critical care medicine in cases of severe illness.

According to the research report, “Global Intravenous (IV) Equipment Market Overview, 2023-28” published by Bonafide Research, the market is anticipated to cross USD 20 Billion by 2028, increasing from USD 14.02 Billion in 2022. The market is expected to grow with more than 6.72% CAGR by 2023-28. The Intravenous (IV) Equipment Industry is experiencing robust growth driven by a convergence of factors that underscore its critical role in modern healthcare. Technological advancements play a pivotal role, with innovations such as smart infusion pumps, connectivity features, and data analytics enhancing the precision and safety of intravenous therapies. The increasing prevalence of chronic diseases globally, coupled with a growing aging population, has led to a sustained demand for intravenous treatments, thereby driving the market's expansion. Moreover, the industry has responded to the challenges posed by the COVID-19 pandemic by demonstrating its indispensability in providing essential intravenous therapies for managing severe cases. The shift towards telemedicine and home-based care has further propelled the development of portable and user-friendly IV equipment, expanding its reach beyond traditional healthcare settings. As regulatory bodies prioritize patient safety, manufacturers are incorporating features like antimicrobial coatings and safety mechanisms in catheters, contributing to the overall growth and evolution of the IV Equipment Industry. Additionally, the Intravenous (IV) Equipment Industry's growth can be attributed to its pivotal role in addressing a wide range of medical conditions, from routine treatments to critical care interventions. The versatility of intravenous therapies, facilitated by IV equipment, has made them integral in various medical specialties, including oncology, cardiology, infectious diseases, and emergency medicine. The industry's ability to adapt to the changing landscape of healthcare, including a shift towards personalized medicine and the integration of digital health solutions, has further positioned it at the forefront of advancements. Furthermore, the emphasis on patient-centric care has spurred the development of IV equipment designed to enhance the overall patient experience. User-friendly interfaces, reduced noise levels, and the ability to administer intravenous therapies in home settings contribute to improved patient satisfaction and adherence to treatment plans. As healthcare providers recognize the importance of data-driven decision-making, the integration of connectivity features in IV equipment allows for real-time monitoring and adjustment of infusion parameters, adding a layer of sophistication to patient care.

The Asia-Pacific region is emerging as a significant player in the Intravenous (IV) Equipment market, experiencing substantial growth attributed to various factors. The region's burgeoning population, rapid urbanization, and increasing healthcare awareness are fostering a rising demand for advanced medical technologies, including IV equipment. A surge in chronic diseases, coupled with lifestyle changes, has led to an uptick in the need for intravenous therapies, contributing to the market's expansion. Additionally, improving economic conditions in several Asia-Pacific countries have facilitated increased healthcare spending, enabling healthcare facilities to invest in state-of-the-art IV equipment. Technological advancements and a growing emphasis on healthcare infrastructure development further bolster the region's position in the IV equipment market. Moreover, the COVID-19 pandemic has underscored the importance of robust healthcare systems, prompting governments and healthcare providers in the Asia-Pacific to enhance their medical capabilities, including intravenous therapy solutions. As the region continues to witness these demographic and economic shifts, it is poised to play an increasingly pivotal role in the global IV equipment market. The growth of drip chambers in the Intravenous (IV) Equipment market can be attributed to their crucial role in ensuring precise and controlled fluid administration during intravenous therapies. Drip chambers act as a critical component in IV administration sets, regulating the flow of fluids into the patient's bloodstream. The increasing demand for intravenous therapies, driven by a rise in chronic diseases and a growing aging population, has amplified the need for accurate and reliable drip chamber technology. Technological advancements have further enhanced drip chamber designs, incorporating features such as air-elimination filters, anti-siphon valves, and pressure-sensing capabilities to optimize fluid control and prevent air embolisms. The emphasis on patient safety and the reduction of healthcare-associated infections has led to the development of drip chambers with enhanced materials and designs, contributing to their growing prominence in the IV equipment market. As healthcare providers prioritize precision and safety in intravenous therapy, the drip chamber's pivotal role in maintaining infusion accuracy continues to drive its growth and adoption in the ever-evolving landscape of medical technology.

The growth of home care settings in the Intravenous (IV) Equipment market is a reflection of the evolving landscape of healthcare delivery, emphasizing patient-centric care and the shift towards decentralized treatment options. Increasingly, patients prefer receiving intravenous therapies in the comfort of their homes, and advancements in IV equipment have facilitated this trend. Home care settings provide a convenient and cost-effective alternative for managing chronic conditions that require regular intravenous treatments, such as chemotherapy, antibiotic therapies, or hydration. The development of portable and user-friendly IV equipment, including infusion pumps and catheters, enables healthcare providers to extend the benefits of intravenous therapies beyond traditional hospital settings. Additionally, the COVID-19 pandemic has accelerated the adoption of telemedicine and home-based care, further boosting the demand for IV equipment suitable for use in home care settings. As the healthcare industry continues to embrace this patient-centric approach, the Intravenous Equipment market is witnessing a significant expansion driven by the increasing integration of IV therapies into home-based healthcare solutions. The escalating growth of cardiovascular disorders and hypertension in the Intravenous (IV) Equipment market is closely tied to the rising prevalence of these conditions globally. Cardiovascular diseases, including heart failure and various forms of hypertension, are becoming increasingly prevalent, contributing to a higher demand for intravenous therapies as part of their treatment protocols. The urgency often associated with managing cardiovascular emergencies, such as acute myocardial infarction or hypertensive crises, underscores the critical need for precise and rapid intravenous medication administration, driving the adoption of advanced IV equipment. Intravenous routes are essential for the immediate delivery of medications like anticoagulants, vasodilators, and inotropes crucial for stabilizing patients with cardiovascular conditions. Moreover, advancements in interventional cardiology and catheter-based procedures further propel the use of IV equipment for delivering contrast agents and medications during sophisticated cardiovascular interventions. As the global burden of cardiovascular disorders continues to rise, the Intravenous Equipment market is poised for sustained growth, addressing the intricate and urgent therapeutic requirements associated with these prevalent health conditions.

Market Drivers

• Aging Population: The global aging population contributes to an increased prevalence of age-related conditions, such as cardiovascular diseases and cancer, which often require intravenous therapies. The demographic shift towards an older population further propels the demand for IV equipment.

• Rise in Ambulatory Care and Home Infusion: The growing trend of shifting healthcare services from traditional hospital settings to ambulatory care and home-based settings increases the need for portable and user-friendly IV equipment. Patients are increasingly receiving intravenous therapies outside of hospitals, influencing product design and functionality.

Market Challenges

• Cost Constraints and Reimbursement Issues: Cost constraints and reimbursement challenges in healthcare systems globally can impact the adoption of advanced IV equipment. Healthcare providers may face limitations in budget allocations for new technologies, affecting the widespread adoption of the latest IV equipment innovations.

• Complex Regulatory Landscape: The IV equipment industry is subject to complex and evolving regulatory frameworks. Navigating regulatory requirements and ensuring compliance can be challenging for manufacturers, influencing the time-to-market for new products and innovations.

Market Trends

• Focus on Environmental Sustainability: There is a growing awareness of environmental sustainability in the healthcare industry. Manufacturers are increasingly incorporating eco-friendly materials, reducing waste, and designing products with a focus on environmental impact to align with global sustainability goals.

• Personalized Medicine and IV Therapies: Advancements in genomics and personalized medicine are influencing the development of tailored intravenous therapies. The trend involves creating IV medications and treatment plans customized to an individual patient's genetic makeup and specific health needs.

• Global Expansion and Market Penetration: Leading companies in the IV equipment industry are focusing on global expansion and market penetration. This involves entering new geographical markets, forming strategic partnerships, and collaborating with healthcare providers to broaden the reach of IV equipment.

Competitive Landscape

Major market players profiled in the report are Becton, Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Medtronic PLC, Moog Inc., Terumo Corporation, Teleflex Incorporated, IRadimed Corporation, Amsino International, Inc. , Cardinal Health, Inc., Codan US Corporation, Elcam Medical Inc, Hindustan Syringes & Medical Devices Ltd., Harsoria Healthcare Pvt Ltd , Nipro Corporation, Polymedicure, 3M, Vygon SAS and Zyno Medical, LLC etc.

Key Developments

• In August 2022, Lineus Medical's SafeBreak vascular received a Japanese utility patent, and the bifurcated venous access device (BVAD), a dual-lumen peripheral IV catheter, received a United States utility patent.

• In July 2022, B. Braun Medical Inc. launched its new Introcan Safety 2 IV Catheter with one-time blood control.

• In May 2019, B.Braun Medical announced that it intends to invest in the development of advanced IV infusion production facilities, which will make vital intravenous fluids safer and more productive when used by medical professionals on a regular basis.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global IV Equipment market with its value and forecast along with its segments
• Region-wise IV Equipment market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report

• North America
• Europe
• Asia-Pacific
• South America
• Middle-East & Africa

By Product:

• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others

By End User:

• Hospital
• Clinics
• Home Care Settings
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the IV Equipment industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.







***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents